Extracellular signal-regulated kinase 1/2-mediated transcriptional regulation of G-protein-coupled receptor kinase 3 expression in neuronal cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 1, 2007, Pages 51-59

  Salim, Samina ^a   Standifer, Kelly M ^a,b   Eikenburg, Douglas C ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CHELERYTHRINE; G PROTEIN COUPLED RECEPTOR KINASE 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHENTOLAMINE; PROPRANOLOL; PROTEIN KINASE C INHIBITOR; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ALKALOIDS; BENZOPHENANTHRIDINES; BETA-ADRENERGIC RECEPTOR KINASE; BLOTTING, WESTERN; CELL LINE, TUMOR; ENZYME INHIBITORS; EPINEPHRINE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; PHENTOLAMINE; PROPRANOLOL; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 33947359339     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.116921     Document Type: Article

References (36)

1. Andresen BT, Romero GG, and Jackson EK (2004) AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cells. J Pharmacol Exp Ther 309:425-431.
2. Arriza JL, Dawson TM, Simerly RB, Martin LJ, Caron MG, Snyder SH, and Lefkowitz RJ (1992) The G-protein-coupled receptor kinases beta ARK1 and beta ARK2 are widely distributed at synapses in rat brain. J Neurosci 12:4045-4055.
3. Barrett TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, Keck PE, McElroy SL, Alexander M, Shaw SH, and Kelsoe JR (2003) Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder. Mol Psychiatry 8:546-557.
4. Bawa T, Altememi GF, Eikenburg DC, and Standifer KM (2003) Desensitization of alpha 2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by beta 2-adrenoceptor-dependent GRK3 up-regulation. Br J Pharmacol 138:921-931.
5. Choi DJ, Koch WJ, Hunter JJ, and Rockman HA (1997) Mechanism of beta-adrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase. J Biol Chem 272:17223-17229.
6. Dautzenberg FM and Hauger RL (2001) G-protein-coupled receptor kinase 3- and protein kinase C-mediated desensitization of the PACAP receptor type 1 in human Y-79 retinoblastoma cells. Neuropharmacology 40:394-407.
7. Dautzenberg FM, Wille S, Braun S, and Hauger RL (2002) GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization. Biochem Biophys Res Commun 298:303-308.
8. De Blasi A, Parruti G, and Sallese M (1995) Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes: selective increase of beta-adrenergic receptor kinase 1 and 2. J Clin Investig 95:203-210.
9. Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, and Lefkowitz RJ (1997) Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors: convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem 272:19125-19132.
10. Desai AN, Salim S, Standifer KM, and Eikenburg DC (2006) Involvement of G protein-coupled receptor kinase (GRK) 3 and GRK2 in down-regulation of the alpha2B-adrenoceptor. J Pharmacol Exp Ther 317:1027-1035.
11. Desai AN, Standifer KM, and Eikenburg DC (2005) Cellular G protein-coupled receptor kinase levels regulate sensitivity of the α2b-adrenergic receptor to undergo agonist-induced down-regulation. J Pharmacol Exp Ther 312:767-773.
12. Desai AN, Standifer KM, and Eikenburg DC (2004) Simultaneous α2B- and beta2-adrenoceptor activation sensitizes the α2b-adrenoceptor for agonist-induced down-regulation. J Pharmacol Exp Ther 311:794-802.
13. αq-mediated cardiac hypertrophy and ventricular dysfunction. Mol Pharmacol 57:278-287.
14. Dzimiri N, Muiya P, Andres E, and Al-Halees Z (2004) Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases. Eur J Pharmacol 489:167-177.
15. Gros R, Benovic JL, Tan CM, and Feldman RD (1997) G-protein-coupled receptor kinase activity is increased in hypertension. J Clin Investig 99:2087-2093.
16. Kelsoe JR, Spence MA, Loetscher E, Foguet M, Sadovnick AD, Remick RA, Flodman P, Khristich J, Mroczkowski-Parker Z, Brown JL, et al. (2001) A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22. Proc Natl Acad Sci USA 98:585-590.
17. Lachman HM, Kelsoe JR, Remick RA, Sadovnick AD, Rapaport MH, Lin M, Pazur BA, Roe AM, Saito T, and Papolos DF (1997) Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. Am J Med Genet 74:121-128.
18. Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lanca AJ, O'Dowd BF, and George SR (2004) Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279:35671- 35678.
19. Lombardi MS, Kavelaars A, Cobelens PM, Schmidt RE, Schedlowski M, and Heijnen CJ (2001) Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol 166:1635-1640.
20. Mak JC, Chuang TT, Harris CA, and Barnes PJ (2002) Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung. Eur J Pharmacol 436:165-172.
21. McLaughlin JP, Myers LC, Zarek PE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, and Chavkin C (2004) Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem 279:1810-1818.
22. Milanini J, Vinals F, Pouyssegur J, and Pages G (1998) p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts. J Biol Chem 273:18165-18172.
23. Niculescu AB 3rd, Segal DS, Kuczenski R, Barrett T, Hauger RL, and Kelsoe JR (2000) Identifying a series of candidate genes for mania and psychosis: a convergent functional genomics approach. Physiol Genomics 4:83-91.
24. Palchaudhuri MR, Hauger RL, Wille S, Fuchs E, and Dautzenberg FM (1999) Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J Neuroendocrinol 11:419-428.
25. Penela P, Alvarez-Dolado M, Munoz A, and Mayor F Jr (2000) Expression patterns of the regulatory proteins G protein-coupled receptor kinase 2 and beta-arrestin 1 during rat postnatal brain development: effect of hypothyroidism. Eur J Biochem 267:4390-4396.
26. Penela P, Murga C, Ribas C, Tutor AS, Peregrin S, and Mayor F Jr (2006) Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc Res 69:46-56.
27. Penn RB, Pronin AN, and Benovic JL (2000) Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med 10:81-89.
28. Prinster SC, Holmqvist TG, and Hall RA (2006) Alpha-2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta-2-adrenergic receptors. J Pharmacol Exp Ther 318:974-981.
29. Ramos-Ruiz R, Penela P, Penn RB, and Mayor F Jr (2000) Analysis of the human G protein-coupled receptor kinase 2 (GRK2) gene promoter: regulation by signal transduction systems in aortic smooth muscle cells. Circulation 101:2083-2089.
30. Salim S, Sinnarajah S, Kehrl JH, and Dessauer CW (2003) Identification of RGS2 and type V adenylyl cyclase interaction sites. J Biol Chem 278:15842-15849.
31. Schmitt JM and Stork PJ (2000) 2-Adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein rap1 and the serine/threonine kinase B-Raf. J Biol Chem 275:25342-25350.
32. Sefton M, Blanco MJ, Penela P, Mayor F, and Nieto MA (2000) Expression of the G protein-coupled receptor kinase 2 during early mouse embryogenesis. Mech Dev 98:127-131.
33. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
34. Theilade J, Hansen JL, Haunso S, and Sheikh SP (2005) MAP kinase protects G protein-coupled receptor kinase 2 from proteasomal degradation. Biochem Biophys Res Commun 330:685-689.
35. Ungerer M, Bohm M, Elce JS, Erdmann E, and Lohse MJ (1993) Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87:454-463.
36. Yu X, Zhang M, Kyker K, Patterson E, Benovic JL, and Kem DC (2000) Ischemic inactivation of G protein-coupled receptor kinase and altered desensitization of canine cardiac beta-adrenergic receptors. Circulation 102:2535-2540.